EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Swiss Orthopaedics Minimal Dataset: First Pilot Report of Reliability and Validity

Thorsten Jentzsch, Claudio Dora, Urs Müller, Mazda Farshad

Advances in Orthopedics · 2020-12-29 · 2020 · 1-4

DOI: 10.1155/2020/6673175 ↗
AbstractBibliografische Angaben

Abstract

Background. The Swiss Orthopaedics Minimal Dataset (SOMD) was launched seven years ago. It is a standardized, generic, and patient-reported outcome questionnaire, comprising ten items (location of disease, pain within the past four weeks, limitations at work/leisure/sleep/autonomy, subjective value of a body part, employment status, work disability (sick leave/pension), and household support). We conducted this study about the SOMD to report its reliability, validity, and clinical applicability. Methods. A retrospective observational cohort study was conducted. The test-retest study population (n = 60; lost to follow-up: n = 7 (12%)) was drawn from three retirement homes (in 2013), while the test study population (n = 14,180; excluded (e.g., duplicates): n = 1,990 (14%)) consisted of patients from a university hospital (in 2014–2017). In the test-retest study population, the same questionnaire was completed twice (at days 0 and 7). In the test study population, only the first questionnaire was included (to avoid duplicates). In a subgroup of the test study population (n = 302), only those patients who completed the SOMD and Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) of the hip within 14 days were considered (to minimize recall bias). Reliability (test-retest and internal consistency), criterion validity for the item of pain, and return rates were analyzed. Results. The test-retest study population (n = 53) showed very high test-retest reliability for all tested items of the SOMD (intraclass correlation coefficient = 0.96–1.00 (95% confidence interval 0.93–1.00), p < 0.001 ). The test study population (n = 12,190) revealed good internal consistency reliability for all ten items (Cronbach’s alpha = 0.80). The return rates of the SOMD were improvable (43% in 2016 and 31% in 2017). The subgroup of the test study population (n = 302) displayed a borderline acceptable criterion validity (correlation of the item of pain between SOMD and WOMAC hip: rho = 0.62, p < 0.001 ). Conclusion. This is the first report about the validation of the SOMD. A relatively high reliability (test-retest and internal consistency), borderline acceptable (criterion) validity for the item of pain, and improvable clinical implementation were observed. This analysis serves as the basis for a structured modification of the SOMD to improve its value.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →